ColonES®

Advancing Early Detection of Colorectal Cancer through Non-Invasive Blood-Based Screening. This assay captures circulating tumor DNA (ctDNA) methylation signals in a small blood sample, employing high-throughput next-generation sequencing technology. With superior sensitivity and specificity compared to stool-based methods, ColonES® offers a patient-friendly blood-based alternative for colorectal cancer detection.